Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Enrolling by invitation × Metronidazole × Clear all

Phase

Phase NA 1 Phase 4 1

Status

Withdrawn 1 Recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

sintilimab 1 bismuth tripotassium dicitrate 1 Tetracycline 1 Tacrolimus 1 Tablets 1 Ropivacaine 1 Mycophenolic Acid 1 Metronidazole 1 Magnetic Resonance Spectroscopy 1 Lacteol 1 Infliximab 1 Gastrointestinal Microbiome 1 Fluorouracil 1 Eye Enucleation 1 Everolimus 1 Esomeprazole 1 Enoxaparin 1 Drug Therapy 1 Cryotherapy 1 Cabergoline 1 CT-P13 1 Azathioprine 1 Aspirin 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04527055 2024-06-24

Bsm10

National Cheng-Kung University Hospital

Phase 4 Enrolling by invitation

Dysbiosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡